OverT Bio
Latest round
- Seed
Last raised
- May 2024
Total raised
- $12M
Investors
- 9
About OverT Bio
Founded in 2022 by co-founders Mat Legut and Neville Sanjana and based in New York, the US, OverT Bio is developing cellular therapies for solid tumours. The company utilizes platforms to engineer immune cells for effective and safe cancer treatment. In May 2024, OverT Bio, Inc. OverT Bio focuses on the research and development of cellular therapies for solid tumors. The work centers on engineering immune cells, specifically T cells, to cure cancer. The company uses its proprietary platforms, OverTarget and OverTune, for pooled functional screening and synthetic genomics to develop these engineered immune cells. OverTarget involves a method for large-scale functional screening to identify genes or pathways that can enhance T cell activity against cancer cells. OverTune is a platform for synthetic genomics, allowing for precise genetic modifications in T cells to improve their targeting and anti-tumor function.
Who invested in OverT Bio
9 investors across 1 round
See all investors in OverT Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
May 9, 2024
Amount
$12M
Investors
Questions about OverT Bio
Who invested in OverT Bio?
OverT Bio has 9 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has OverT Bio raised?
OverT Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did OverT Bio last raise money?
OverT Bio's most recent round on record is a Seed, in May 2024.
What does OverT Bio do?
Founded in 2022 by co-founders Mat Legut and Neville Sanjana and based in New York, the US, OverT Bio is developing cellular therapies for solid tumours.
Where is OverT Bio headquartered?
OverT Bio is headquartered in New York, US.
Which VCs invest in companies like OverT Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at OverT Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like OverT Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.